Comparing ultrasound and laser therapy for diabetic foot pain
Comparative Effects of Therapeutic Ultrasound and High Intensity Laser Therapy on Neuropathic Pain ,Strength and Quality of Life in Diabetic Foot
This study tests whether ultrasound or high-intensity laser therapy can help people with diabetic foot pain feel better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 46 (estimated) |
| Ages | 50 Years to 75 Years |
| Sex | All |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Bahawalpur, Punjab Province) |
| Trial ID | NCT06479577 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the effects of therapeutic ultrasound and high intensity laser therapy on neuropathic pain, strength, and quality of life in patients suffering from diabetic foot. It involves administering these therapies alongside routine physical therapy to assess their effectiveness in alleviating symptoms associated with diabetic neuropathy. Given the limited evidence on high intensity laser therapy, this investigation seeks to fill a critical gap in understanding its potential benefits compared to ultrasound treatment.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 50 to 75 with type 2 diabetes and diagnosed diabetic neuropathy experiencing pain in the lower extremities for at least six months.
Not a fit: Patients with severe neurological disorders, recent surgeries, or other significant health issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide new treatment options for patients suffering from diabetic neuropathy, potentially improving their pain management and quality of life.
How similar studies have performed: While the application of high intensity laser therapy is relatively novel, similar studies using therapeutic ultrasound have shown promising results in managing neuropathic pain.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with type 2 diabetes. * Diabetic Patients of age 50 to 75 years. * Diabetic patient of Both genders * Diagnosed Diabetes Mellitus with at least 7 years of duration * Distal symmetrical or asymmetrical polyneuropathy with pain in the lower extremity for ≥6 months * DNS (Diabetic neuropathy symptoms questionnaire) score greater than 4 (90 percent probability of neuropath Exclusion Criteria: * Pregnant females * Lower limb Amputated patients * History or evidence of neurological disorders other than peripheral neuropathy associated with Diabetes mellitus. * Evidence of musculoskeletal dysfunctions like scoliosis, lumbar disc prolapses and lumbar spine associated radiculopathy. * History of any low back surgeries and lower limb surgeries * Patient with malignancy. Patient with epilepsy * Patient with hemophilia * Patient with pacemaker, metal implants prosthesis and internal fixation screws. * Patient with severe cervical and lumbar neuropathy, rheumatoid arthritis, hereditary neuropathy * Patient with a history of neurosurgery
Where this trial is running
Bahawalpur, Punjab Province
- Bahawalpur medical and dental hospital — Bahawalpur, Punjab Province, Pakistan (Recruiting)
Study contacts
- Principal investigator: Aruba Saeed, Phd — Riphah International University
- Study coordinator: Imran Amjad, Phd
- Email: Imran.amjad@riphah.edu.pk
- Phone: 03324390125
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.